PUT - SPRINTER OPEN END - BRISTOL-MYERS SQUIBB | Market Closed - Börse Stuttgart 15:37:03 2024-06-26 EDT | ||
| 4.48 EUR | -0.44% |
|
| Current month | -1.75% | ||
| 1 month | -1.10% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-26 | 4.48 | -0.44% |
| 24-06-25 | 4.5 | +0.22% |
| 24-06-24 | 4.49 | -1.32% |
| 24-06-21 | 4.55 | -1.30% |
| 24-06-20 | 4.61 | +0.44% |
Delayed Quote Börse Stuttgart
Last update June 26, 2024 at 03:37 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Vontobel
|
| WKN | VV39WT |
| ISIN | DE000VV39WT9 |
| Date issued | 2022-06-28 |
| Strike | 90.45 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.29 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.68 € |
|---|---|
| Lowest since issue | 1.01 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
42.5
USD
Average target price
53.19
USD
Spread / Average Target
+25.16%
- Stock Market
- Certificates
- Certificat
